Lumos Pharma Inc (LUMO)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4200 MARATHON BLVD. AUSTIN, TX 78756

Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé Ventures, and UCB. Lumos Pharma's lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2b clinical trial, the OraGrowtH210 Trial, for the treatment of Pediatric Growth Hormone Deficiency (PGHD). If approved by the FDA, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU.

Data as of 2021-07-19 09:00:41 -0400
Market Cap80.109 Million Shares Outstanding8.345 Million Avg 30-day Volume18.96 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.56107 52-week High/Low36.72 / 9.5 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from LUMO instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 43 49 -12.24% 11 (0.65%) 14 (0.81%) -21.43%
13F shares: 3.315 Million 3.77 Million -12.05% 1.606 Million 2.107 Million -23.79%
% Ownership 39.8215 45.4329 -12.35% 19.2841 25.3927 -24.06%
New Positions: 6 13 -53.85% 2 4 -50.0%
Increased Positions 12 7 71.43% 5 2 150.0%
Closed Positions 11 4 175.0% 4 1 300.0%
Reduced Positions 5 12 -58.33% 2 5 -60.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LUMO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LUMO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHUCHART AARON CHIEF BUSINESS OFFICER

  • Officer
7,805 2021-06-01 2

RAFFIN THOMAS A.

  • Director
11,166 2021-05-20 1

ZOTH LOTA S.

  • Director
5,097 2021-05-20 1

JOHNSON CHAD ALLEN

  • Director
3,986 2021-05-20 1

LALANDE KEVIN M.

  • Director
413,613 2021-05-20 1

MCCRACKEN JOSEPH S

  • Director
3,986 2021-05-20 1

VAN ES-JOHANSSON AN

  • Director
4,010 2021-05-20 2

LANGREN CARL W. CHIEF FINANCIAL OFFICER

  • Officer
17,015 2021-04-01 2

LAWLEY LORI D PRINCIPAL ACCOUNTING OFFICER

  • Officer
5,437 2021-04-01 2

POWERS BRADLEY J GENERAL COUNSEL

  • Officer
5,109 2021-04-01 2

HAWKINS RICHARD J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
745,382 2021-04-01 2

MCKEW JOHN C. CHIEF SCIENTIFIC OFFICER

  • Officer
13,226 2021-04-01 2

KENNEDY EUGENE P. CHIEF MEDICAL OFFICER

  • Officer
11,423 2021-02-01 1

FLYNN JAMES E

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • *POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2021-01-06 1

CUNNINGHAM EMMETT

  • Director
709 2020-04-03 0

LINK CHARLES J. JR. CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
0 2019-08-02 0

VAHANIAN NICHOLAS N. PRESIDENT

  • Officer
0 2019-07-31 0

TALARICO ERNEST III

  • Director
0 2019-07-31 0

SHERMAN MATTHEW L

  • Director
0 2019-07-31 0

HENNEMAN JOHN B III CHIEF ADMINISTRATIVE OFFICER

  • Officer
55,052 2018-10-01 0

PUCCI PAOLO

  • Director
0 2018-05-23 0

WILEY BRIAN CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-03-09 0

STINE SEED FARM, INC.

  • 10% Owner
7,857,732 2017-10-06 0

EDICK PAUL R

  • Director
0 2017-05-12 0

SALURI JOSEPH

  • Director
0 2017-05-12 0

RAMSEY WILLIAM J. QUALITY ASSURANCE OFFICER

  • Officer
No longer subject to file 2015-06-01 0

LINK GORDON H JR CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2014-10-24 0

LYNN KENNETH

  • NO LONGER REPORTING OFFICER
No longer subject to file 2012-06-27 0

LUNDQUIST DAVID J.

  • Director
87,630 2011-11-16 0

ALEXANDER SARAH

  • Director
5,833 2011-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SCHUCHART AARON - Officer CHIEF BUSINESS OFFICER

2021-06-03 16:52:33 -0400 2021-06-01 A 7,805 a 7,805 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LUMOS PHARMA INC LUMO 2021-07-23 22:15:03 UTC -3.1698 3.2498 100000
LUMOS PHARMA INC LUMO 2021-07-23 21:45:03 UTC -3.1663 3.2463 100000
LUMOS PHARMA INC LUMO 2021-07-23 21:15:03 UTC -3.1663 3.2463 100000
LUMOS PHARMA INC LUMO 2021-07-23 20:45:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 20:15:05 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 19:45:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 19:15:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 18:45:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 18:15:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 17:45:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 17:15:02 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 16:45:02 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 16:15:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 15:45:02 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 15:15:03 UTC -3.1365 3.2165 100000
LUMOS PHARMA INC LUMO 2021-07-23 14:45:03 UTC -3.2633 3.3433 100000
LUMOS PHARMA INC LUMO 2021-07-23 14:15:03 UTC -3.2633 3.3433 100000
LUMOS PHARMA INC LUMO 2021-07-23 13:45:03 UTC -3.2633 3.3433 100000
LUMOS PHARMA INC LUMO 2021-07-23 13:15:03 UTC -3.2633 3.3433 100000
LUMOS PHARMA INC LUMO 2021-07-23 12:45:03 UTC -3.2633 3.3433 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund LUMO -222.0 shares, $-2597.4 2021-03-31 N-PORT

Elevate your investments